Latest News

Magnetic Seeds/Guidewires for Breast Cancer Localization? Paramagnetic seeds work as well as guidewires for breast tumor localization and are easier to use, but it's not yet clear whether the costs of the seeds outweigh the benefits.
Medscape Medical News, January 05, 2024
Newborn Recipient of Partial Heart Transplant Doing Well The world's first transplantation of aortic and pulmonary valves into a neonate delivered a good outcome, and the valves showed continued adaptive growth and function.
Medscape Medical News, January 05, 2024
Impact of Pregnancy on Rosacea Unpredictable, Study Suggests Nearly half of study participants reported that their rosacea worsened when they were pregnant.
Medscape Medical News, January 05, 2024
Wegovy, Ozempic Not Linked to Increase in Suicidal Thoughts, US Study Finds A large U.S. study found no evidence that taking Novo Nordisk's Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported on Friday.
Reuters Health Information, January 05, 2024
Mortality Still Significant in High-Risk PE Despite Advances A new study showed continued high rates of in-hospital mortality in patients with high-risk PE, despite advances in treatment and creation of PE response teams.
Medscape Medical News, January 05, 2024
Long-term Clopidogrel Has Advantages After Coronary Stenting Clopidogrel after PCI was noninferior to aspirin for net adverse clinical events but superior in reducing secondary endpoints of stroke and MI, in 5-year STOPDAPT-2 results.
Medscape Medical News, January 05, 2024
Merck Seeks GLP-1 Drugs With Benefits Beyond Weight Loss - CEO Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.
Reuters Health Information, January 04, 2024
'Left in the Dark': Prior Auth Erodes Trust, Costs More A surprising prior authorization requirement left an oncologist's patient in extreme pain over the weekend.
Medscape Medical News, January 04, 2024
US Dermatologic Drug Approvals Rose Between 2012 and 2022 Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said.
Medscape Medical News, January 04, 2024
Higher-Dose Atypical Antipsychotics Risky in Young Adults Higher doses of a second-generation antipsychotic are associated with an increased risk of dying in young adults aged 18-24 years, results of a large retrospective cohort study showed.
Medscape Medical News, January 04, 2024
Lilly Launches Website, Home Delivery Option for Weight-loss Drug Eli Lilly and Co on Thursday launched a website to enable people to directly order from the drugmaker including its weight-loss medicine Zepbound as well as connect people...
Reuters Health Information, January 04, 2024
Ten Ways Your Telehealth Backdrop Can Improve Patient Care A well-curated background and presentation during virtual visits are more important than ever now.
Medscape Medical News, January 04, 2024
Prior Auth Tied to Delays, Discontinuation of Cancer Meds The introduction of a new prior authorization requirement for an established oral anticancer regimen led to more treatment delays and discontinuations among Medicare beneficiaries.
Medscape Medical News, January 04, 2024
Wegovy Maker Novo Nordisk Enters Research Tie-ups With US Biotech Firms Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big pharma's...
Reuters Health Information, January 04, 2024
Why Do MDs Have Such a High Rate of Eating Disorders? Data suggested medical professionals may have eating disorders at twice the rate of the population — while few talk about it. Here's what to know.
Medscape Medical News, January 04, 2024
Virtual Visits With One's Own PCP Tied to Fewer ED Visits Recent findings add to a growing body of evidence that suggests that virtual care is most beneficial when provided within an existing therapeutic relationship, a researcher said.
Medscape Medical News, January 04, 2024
Assessing Patients With AD: Tools to Use in the Office "It can be overwhelming because there are many choices but so little time," says Dr Jonathan Silverberg, of George Washington University, Washington, DC.
MDedge News, January 04, 2024
Experimental Topical Drug Shows Promise for AD, Psoriasis In the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks.
MDedge News, January 04, 2024
Pediatric Obesity Specialists Struggle to Get GLP-1s The medications can reduce or eliminate weight-related complications in children but are in short supply, and insurers are denying coverage, said pediatricians.
Medscape Medical News, January 03, 2024
AI Shows Potential for Detecting Mucosal Healing in UC Use of standardized, shared AI training data could improve new machine learning algorithms even more.
Medscape Medical News, January 03, 2024
Replimune Skin Cancer Therapy Fails Midstage Study Replimune Group said on Tuesday its experimental combination therapy to treat a common form of skin cancer failed to significantly remove or reduce cancerous lesions in a midstage study.
Reuters Health Information, December 05, 2023
Alcohol Taxes Aren't High Enough, Says World Health Organization WHO urged governments on Tuesday to increase taxes on alcoholic drinks and impose them on products that are currently exempt, such as wine in some European countries.
Reuters Health Information, December 05, 2023
CVS Plans to Simplify Drug Pricing Process CVS Health on Tuesday forecast 2024 revenue above market estimates and said it would simplify the structure through which its pharmacies get reimbursed for drugs.
Reuters Health Information, December 05, 2023
US Regulators Inspect Dr Reddy's, Other Indian Pharma Majors The US Food and Drug Administration is inspecting Dr Reddy's research and development centre in the southern Indian city of Hyderabad, the pharma company said on Tuesday.
Reuters Health Information, December 05, 2023
Eli Lilly Obesity Drug Now Available in US Pharmacies
Reuters Health Information, December 05, 2023
Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly.
Reuters Health Information, December 04, 2023
MSWS 2023 What's New in Acne Treatment? Advances in acne care include the use of light-based devices.
Medscape Medical News, December 04, 2023
How the New Outbreak in China Is Hitting Clinics Elsewhere A rise in respiratory illnesses in China, clusters of pneumonia in children, and resistance to common antibiotics have specialists on alert looking for changes locally.
Medscape Medical News, December 04, 2023
'Hidden Hearing Loss' May Cause Tinnitus: Study Some people who have tinnitus are still able to perform well on standard hearing tests, according to researchers at the Massachusetts Eye and Ear Infirmary.
WebMD Health News, December 04, 2023
ASH 2023 ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
MDedge News, December 04, 2023
Analysis Supports Link Between Psoriasis and OSA Several hypotheses may explain the connection, such as the presence of inflammatory mediators and nocturnal cytokine secretion, according to the authors.
Medscape Medical News, December 04, 2023
Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
Medscape Medical News, December 04, 2023
Statin Use Remains Low for At-Risk Patients Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.
Medscape Medical News, December 04, 2023
No Benefit of Levothyroxine in Heart Donors New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
Medscape Medical News, December 04, 2023
How the Microbiome Influences the Success of Cancer Therapy Microbial diversity affects whether a tumor grows, leads to inflammation, develops immune escape mechanisms, or develops therapeutic resistance, said an internal medicine specialist.
Medscape Medical News, December 04, 2023
An ED Nurse Crosses Busy Freeway to Save a Life When a huge cement truck slams into a freeway retaining wall, an ED nurse on her way home jumps in with no equipment to prevent a bleed-out.
Medscape Medical News, December 04, 2023
How Gender-Affirming Treatment Affects Erythrocytosis Gender-affirming hormone therapy has been associated with a risk for abnormal blood cell elevation, but a new study finds that it is a lower risk than was previously believed.
Medscape Medical News, December 04, 2023
AES 2023 Poverty Tied to Poor Cognition in Patients With Epilepsy Mounting research links poverty and other elements of neighborhood deprivation to worse cognition in people with epilepsy.
Medscape Medical News, December 04, 2023
Experimental Tx Restores Cognitive Function in Chronic TBI In a first-in-humans trial, deep brain stimulation restored executive function in five individuals with moderate to severe traumatic brain injury 3-18 years after injury.
Medscape Medical News, December 04, 2023
US Obesity Docs Expect Zepbound to Show Heart Benefit Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy.
Reuters Health Information, December 01, 2023

No Results